News • Early-stage disease stratification
Predicting lung cancer outcomes with tumour DNA in the blood
A new personalised oncology platform has been tested to detect circulating tumour DNA (ctDNA) in patients with lung adenocarcinoma before surgery, to predict their risk of cancer relapse.